The document analyzes pharmaceutical market trends in the Middle East and Africa region. It identifies strengths and weaknesses in the Middle East/North Africa market, including burgeoning local production but lack of uniform patent laws. Key players like Qatar and Saudi Arabia are discussed. For sub-Saharan Africa, strengths include local markets and new formulations, while weaknesses are difficulties in drug prequalification and regulation. South Africa and Kenya are highlighted as key sub-Saharan players.

1. Pharmaceutical Market Trend Analysis in the Middle East and Africa By Kingshuk Ghosh

3. North Africa and Middle East

4. Sub - Saharan Africa

5. Middle East and North Africa (market in transition) Strengths Burgeoning local pharmaceutical production industry Focus on generic manufacture Threats No uniformity in product patent laws Large discrepancies in the implementation of Intellectual Property Rights Economic & security risks due to changing geopolitical scene Weaknesses Protectionist regime Regulatory environment poses as tough entry barriers (price controls, parallel imports, economic fluctuations) Opportunities Population growth (higher ave. annual projected population growth at 1.7%) Rising consumer demand International pressure to instill fair trade (WTO)

12. Facts & Figures

16. Kenya